Saturday, July 01, 2017 5:32:38 PM
re an earlier post re company's arthritis PR of 6/29 and your reply to it: yes...theralase's PDT Cancer treatment is the big potential breakout story here, surely why most are here. But the arthritis pain/inflammation control market is itself a potential multi-billion $$ opportunity for the laser division....IF company can capitalize on it. Unclear from that PR what regulatory hoops company would have to clear to move this forward...or how company intends to address this. Would like to see more specifics re this as it seems, at least on the surface, a market for the 2000 well worth pursuing....
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM